Nisa Investment Advisors, LLC Astrazeneca PLC Transaction History

Nisa Investment Advisors, LLC

$16.7 Billion
Q3 2024

A detailed history of Nisa Investment Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 1,800 shares of AZN stock, worth $120,960. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,800

Previous 1,800 -0.0%

Holding current value

$120,960

Previous $140,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	BUY	$66.81 - $80.83 $93,534 - $113,162	1,400 Added 350.0%	1,800 $140,000
Q1 2024 May 01, 2024	SELL	$61.03 - $69.57 $12,206 - $13,913	-200 Reduced 33.33%	400 $27,000
Q1 2023 May 02, 2023	SELL	$63.15 - $71.6 $2.4 Million - $2.72 Million	-38,000 Reduced 98.45%	600 $42,000
Q4 2022 Feb 02, 2023	BUY	$54.21 - $70.44 $2.06 Million - $2.68 Million	38,000 Added 6333.33%	38,600 $2.62 Million
Q3 2022 Nov 07, 2022	SELL	$53.02 - $135.75 $894,023 - $2.29 Million	-16,862 Reduced 96.56%	600 $33,000
Q1 2022 Apr 29, 2022	BUY	$55.72 - $67.12 $972,982 - $1.17 Million	17,462 New	17,462 $1.16 Million
Q4 2021 Feb 03, 2022	SELL	$54.02 - $63.83 $641,379 - $757,853	-11,873 Closed	0 $0
Q3 2021 Oct 18, 2021	BUY	$55.56 - $60.79 $659,663 - $721,759	11,873 New	11,873 $713,000
Q3 2020 Oct 20, 2020	SELL	$53.07 - $61.1 $254,736 - $293,280	-4,800 Closed	0 $0
Q1 2020 Apr 17, 2020	SELL	$37.79 - $51.33 $41,569 - $56,463	-1,100 Reduced 18.64%	4,800 $214,000
Q4 2019 Jan 17, 2020	SELL	$42.46 - $50.46 $97,658 - $116,058	-2,300 Reduced 28.05%	5,900 $294,000
Q4 2018 Jan 17, 2019	SELL	$36.86 - $41.49 $14,744 - $16,596	-400 Reduced 4.65%	8,200 $311,000
Q3 2018 Oct 16, 2018	BUY	$34.76 - $39.72 $298,936 - $341,592	8,600 New	8,600 $340,000

Others Institutions Holding AZN

# of Institutions

1,360

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $208B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Account

Nisa Investment Advisors, LLC Astrazeneca PLC Transaction History